Concept Pharmaceuticals Ltd.
- A02 - Agentes para el tratamiento de alteraciones causadas por ácidos
- DISOCAIN oral suspension 250 mg/5 ml+250 mg/5 ml+40 mg/5 ml+10 mg/5 ml
- DISOGEL oral suspension 250 mg/5 ml+250 mg/5 ml+40 mg/5 ml+400 mg/5 ml
- DISOGEL tablet
- PANTEC D prolonged-release capsule, hard 20 mg+10 mg
- PANTEC DSR prolonged-release capsule, hard 40 mg+30 mg
- PANTEC gastro-resistant tablet 20 mg
- PANTEC gastro-resistant tablet 40 mg
- PANTEC PLUS prolonged-release capsule, hard 40 mg+15 mg
- PANTEC powder for solution for injection 40 mg
- D07 - Preparados dermatológicos con corticosteroides
- FLUCREME NM cream 0.025%+0.5%+2%
- J01 - Antibacterianos para uso sistémico
- C FORT powder for solution for injection 1 000 mg+500 mg
- C FORT powder for solution for injection 250 mg+125 mg
- LAFIX dispersible tablet 100 mg+40 M Spores
- LAFIX dispersible tablet 50 mg+30 M Spores
- LAFIX oral suspension 50 mg/5 ml+30 M Spores/5 ml
- LAFIX tablet 200 mg+60 M Spores
- OFLAB dispersible tablet 100 mg+30 M Spores
- OFLAB film-coated tablet 200 mg+60 M Spores
- OFLAB film-coated tablet 300 mg+60 M Spores
- OFLAB film-coated tablet 400 mg+60 M Spores
- OFLAB oral suspension 50 mg/5 ml+300 M Spores/5 ml
- OFLAB OZ film-coated tablet 200 mg+500 mg
- OFLAB OZ oral suspension 50 mg/5 ml+125 mg/5 ml
- J04 - Antimicobacterias
- E THIO film-coated tablet 250 mg